Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
L
|
LTC Properties Inc
SWB:LTP
|
US |
|
Chewy Inc
F:3HH
|
US |
|
D'Ieteren Group NV
XBRU:DIE
|
BE |
|
A
|
Argan Inc
F:1AW
|
US |
|
S
|
Sun Life Financial Inc
F:LIE
|
CA |
|
P
|
Polytec Holding AG
XMUN:P4N
|
AT |
|
E
|
Equity LifeStyle Properties Inc
NYSE:ELS
|
US |
|
S
|
Suncor Energy Inc
F:SM3
|
CA |
|
Bioretec Oy
F:0TN
|
FI |
|
A
|
Aeon Thana Sinsap Thailand PCL
SET:AEONTS
|
TH |
|
J
|
J M Smucker Co
DUS:JM2
|
US |
Wall St Price Targets
OTLK Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for OTLK is 5.508 USD with a low forecast of 1.616 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OTLK's stock price target?
Price Target
5.508
USD
According to Wall Street analysts, the average 1-year price target for OTLK is 5.508 USD with a low forecast of 1.616 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
871%
The compound annual growth rate for Gross Profit over the next 3 years is 871%.
